TEISHIMA, J.; HARA, T.; TOBE, T.; HIRATA, J.; UEKI, H.; WAKITA, N.; SHIRAISHI, Y.; OKAMURA, Y.; BANDO, Y.; TERAKAWA, T.; FURUKAWA, J.; HARADA, K.- ichi; NAKANO, Y.; FUJISAWA, M. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma . Canadian Urological Association Journal, [S. l.], v. 18, n. 5, p. E162–6, 2024. DOI: 10.5489/cuaj.8548. Disponível em: https://cuaj.ca/index.php/journal/article/view/8548. Acesso em: 12 may. 2024.